When binding is enough: nonactivating antibody formats
- 31 August 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 20 (4), 479-485
- https://doi.org/10.1016/j.coi.2008.05.010
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 SubclassJournal of Biological Chemistry, 2008
- Human IgG2 Antibodies Display Disulfide-mediated Structural IsoformsJournal of Biological Chemistry, 2008
- Isotype selection in antibody engineeringNature Biotechnology, 2007
- Phase I Evaluation of CDP791, a PEGylated Di-Fab′ Conjugate that Binds Vascular Endothelial Growth Factor Receptor 2Clinical Cancer Research, 2007
- A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivoClinical Cancer Research, 2006
- Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritisArthritis & Rheumatism, 2006
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1Journal of Virology, 2001
- The structural requirements for complement activation by IgG: does it hinge on the hinge?Immunology Today, 1995